Latest news
FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma - The American Journal of Managed CareThe American Journal of Managed Care · Wed, 05 Aug 2026 15:30:00 GMTIsatuximab OBI Cuts Infusion Reactions: Xavier Leleu, MD, PhD - The American Journal of Managed CareThe American Journal of Managed Care · Tue, 28 Jul 2026 07:00:00 GMT